Southwest Research Institute (SwRI), headquartered in San Antonio, Texas, is one of the oldest and largest independent, nonprofit, applied research and development (R&D) organizations in the United States.
Principal Investigator(s)
Dr. Shawn Blumberg
Funded by
Medical CBRN Defense Consortium (MCDC)
Southwest Research Institute has developed a unique technology (US20230242487A1) that enables the safe and efficient synthesis of organophosphorus nerve agent (OPNA) oxime antidotes. Using this technology, SwRI scientists can not only successfully synthesize currently known highly effective nerve agent countermeasures, but also effectively develop promising new drug candidates to treat nerve agent exposure.
Southwest Research Institute (SwRI), headquartered in San Antonio, Texas, is one of the oldest and largest independent, nonprofit, applied research and development (R&D) organizations in the United States.
Principal Investigator(s)
Dr. Mark Libardoni
Funded by
Connecting through Research Partnerships (Connect) program
Collaborating Institutions
The University of Texas at San Antonio
Researchers from Southwest Research Institute (SwRI) and The University of Texas at San Antonio (UTSA) are developing techniques to detect traumatic brain injury (TBI) by analyzing breath for specific biomarkers. The project, led by SwRI’s Dr. Mark Libardoni and UTSA’s Dr. Marzieh Memar and Dr. Morteza Seidi, is supported by a $125,000 grant from the Connecting through Research Partnerships (Connect) program.
